Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 3098542, 9 pages
https://doi.org/10.1155/2017/3098542
Research Article

Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients

1Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway
2Department of Gynecologic Oncology, Institute for Cancer Genetics and Informatics and University of Oslo, Oslo, Norway
3MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK
4DOCs International, Buckinghamshire, UK
5Department of Medical Oncology, Catalan Institute of Oncology, Doctor Josep Trueta University Hospital, Girona, Spain
6Department of Medical Sciences, Medical School, University of Girona, Girona, Spain
7Medical Oncology, Royal Prince Alfred Hospital and Concord Repatriation General Hospital and Chris O’Brien Lifehouse, Sydney, NSW, Australia
8Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway

Correspondence should be addressed to Åslaug Helland; on.oiu.nisidem@dnalleha

Received 14 November 2016; Accepted 11 January 2017; Published 15 February 2017

Academic Editor: Ines Zidi

Copyright © 2017 Ann Rita Halvorsen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [14 citations]

The following is the list of published articles that have cited the current article.

  • Xiyin Wang, Mircea Ivan, and Shannon M. Hawkins, “The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer,” Gynecologic Oncology, 2017. View at Publisher · View at Google Scholar
  • Sanjeev K. Srivastava, Aamir Ahmad, Haseeb Zubair, Orlandric Miree, Seema Singh, Rodney P. Rocconi, Jennifer Scalici, and Ajay P. Singh, “MicroRNAs in gynecological cancers: Small molecules with big implications,” Cancer Letters, 2017. View at Publisher · View at Google Scholar
  • M. Janaki Ramaiah, Shaik Mohammad Naushad, P.O.N. Lavanya, A. Gayatri, S. Vaishnave, and Manika Pal-Bhadra, “Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer,” Gene, 2017. View at Publisher · View at Google Scholar
  • Kun Zhou, Kevin W. Diebel, Andrew Skildum, Evan Odean, Juan E. Abrahante, Monique A. Spillman, Lynne T. Bemis, Jon Holy, Douglas A. Hicks, and Brent Schotl, “A tRNA fragment, tRF5-Glu, regulates BCAR3 expression and proliferation in ovarian cancer cells,” Oncotarget, vol. 8, no. 56, pp. 95377–95391, 2017. View at Publisher · View at Google Scholar
  • Rahma Said, Yoelsis Garcia-Mayea, Nesrine Trabelsi, Nouha Setti Boubaker, Cristina Mir, Ahlem Blel, Nidhal Ati, Rosanna Paciucci, Javier Hernández-Losa, Soumaya Rammeh, Amine Derouiche, Mohamed Chebil, Matilde E. LLeonart, and Slah Ouerhani, “Expression patterns and bioinformatic analysis of miR-1260a and miR-1274a in Prostate Cancer Tunisian patients,” Molecular Biology Reports, 2018. View at Publisher · View at Google Scholar
  • Suchitra Kumari, “Serum Biomarker Based Algorithms in Diagnosis of Ovarian Cancer: A Review,” Indian Journal of Clinical Biochemistry, 2018. View at Publisher · View at Google Scholar
  • Wen Liu, Kaiping Zhang, Pengfei Wei, Yue Hu, Yaqin Peng, Xiang Fang, Guoping He, Limin Wu, Min Chao, and Jing Wang, “Correlation between miR-200 Family Overexpression and Cancer Prognosis,” Disease Markers, vol. 2018, pp. 1–16, 2018. View at Publisher · View at Google Scholar
  • Beatriz Teixeira Costa, Isadora Santos Ferreira, and Felipe Fregni, “Generating a Hypothesis for an Oncology Study,” Methods and Biostatistics in Oncology, pp. 9–22, 2018. View at Publisher · View at Google Scholar
  • Maria L. Wikberg, Robin Myte, Richard Palmqvist, Bethany van Guelpen, and Ingrid Ljuslinder, “Plasma miRNA can detect colorectal cancer, but how early?,” Cancer Medicine, 2018. View at Publisher · View at Google Scholar
  • Lydia Giannopoulou, Martha Zavridou, Sabine Kasimir-Bauer, and Evi S. Lianidou, “LIQUID BIOPSY IN OVARIAN CANCER: THE POTENTIAL OF CIRCULATING miRNAs AND EXOSOMES,” Translational Research, 2018. View at Publisher · View at Google Scholar
  • Hirofumi Yoshino, Hideki Enokida, Masaya Yonemori, Kazutaka Miyamoto, Masayuki Nakagawa, Tomokazu Yonezawa, Takashi Sakaguchi, Satoru Sugita, Youichi Osako, and Shuichi Tatarano, “Downregulation of microRNA-1274a induces cell apoptosis through regulation of BMPR1B in clear cell renal cell carcinoma,” Oncology Reports, vol. 39, no. 1, pp. 173–181, 2018. View at Publisher · View at Google Scholar
  • Martina Faraldi, Marta Gomarasca, Giuseppe Banfi, and Giovanni Lombardi, “Free Circulating miRNAs Measurement in Clinical Settings: The Still Unsolved Issue of the Normalization,” 2018. View at Publisher · View at Google Scholar
  • Tomi Akinyemiju, “Epigenetic Biomarkers in Cancer Epidemiology,” Epigenetic Mechanisms in Cancer, pp. 223–241, 2018. View at Publisher · View at Google Scholar
  • George Georgiadis, Charalampos Belantis, Charalampos Mamoulakis, John Tsiaoussis, Wallace A. Hayes, and Aristidis M. Tsatsakis, “Pancreatic and Ovarian Cancer Biomarkers,” Biomarkers in Toxicology, pp. 855–867, 2019. View at Publisher · View at Google Scholar